Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide

This publication has 30 references indexed in Scilit:

• Modulation of carbonic anhydrase activity and its applications in therapy
  Expert Opinion on Therapeutic Patents, 2004
• Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
  Bioorganic & Medicinal Chemistry Letters, 2004
• Designing of Novel Carbonic Anhydrase Inhibitors and Activators
  Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2004
• Review Article
  Journal of Enzyme Inhibition and Medicinal Chemistry, 2004
• Anticancer and Antiviral Sulfonamides
  Current Medicinal Chemistry, 2003
• Carbonic anhydrase inhibitors
  Medicinal Research Reviews, 2002
• Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
  Current Cancer Drug Targets, 2002
• Applications of carbonic anhydrase inhibitors and activators in therapy
  Expert Opinion on Therapeutic Patents, 2002
• Carbonic anhydrase inhibitors and their therapeutic potential
  Expert Opinion on Therapeutic Patents, 2000
• Carbonic anhydrase: chemistry, physiology, and inhibition
  Physiological Reviews, 1967